SIGNATURE RX

Serial Number 97920185
Registration 7726867
700

Registration Progress

Application Filed
May 4, 2023
Under Examination
Approved for Publication
Jan 28, 2025
Published for Opposition
Jan 28, 2025
Registered
Mar 18, 2025

Trademark Image

SIGNATURE RX

Basic Information

Serial Number
97920185
Registration Number
7726867
Filing Date
May 4, 2023
Registration Date
March 18, 2025
Published for Opposition
January 28, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 18, 2025
Registration
Registered
Classes
040

Rights Holder

PharmaPac Holdings

03
Address
1107 Wallace Dr
Delray Beach, FL 33444

Ownership History

PharmaPac Holdings

Original Applicant
03
Delray Beach, FL

PharmaPac Holdings

Owner at Publication
03
Delray Beach, FL

PharmaPac Holdings

Original Registrant
03
Delray Beach, FL

Legal Representation

Attorney
James Juo

USPTO Deadlines

Next Deadline
1905 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250318)
Due Date
March 18, 2031
Grace Period Ends
September 18, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description Documents
Mar 18, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 18, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 28, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 28, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 22, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 2, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 9, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 9, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 9, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 4, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 4, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 4, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 3, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 3, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 3, 2024 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Oct 10, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Oct 10, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
Oct 10, 2024 CNFR R FINAL REFUSAL WRITTEN Loading...
Oct 9, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 9, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 9, 2024 ALIE A ASSIGNED TO LIE Loading...
Jun 25, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 25, 2024 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Jun 25, 2024 PETG O PETITION TO REVIVE-GRANTED Loading...
Jun 25, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
May 20, 2024 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
May 20, 2024 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jan 25, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 25, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 25, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 23, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 2, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 8, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 040
Contract manufacturing in the field of compounded pharmaceuticals
First Use Anywhere: Jun 11, 2014
First Use in Commerce: Jun 11, 2014

Additional Information

Pseudo Mark
SIGNATURE

Classification

International Classes
040

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RX"